Timothy Mant

3.1k total citations · 1 hit paper
42 papers, 1.6k citations indexed

About

Timothy Mant is a scholar working on Genetics, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Timothy Mant has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Timothy Mant's work include Hemoglobinopathies and Related Disorders (10 papers), Lipoproteins and Cardiovascular Health (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Timothy Mant is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Lipoproteins and Cardiovascular Health (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Timothy Mant collaborates with scholars based in United Kingdom, United States and Australia. Timothy Mant's co-authors include James M. Ritter, Joseph Chiesa, Kevin Fitzgerald, Jessica E. Sutherland, Maria Frank-Kamenetsky, Valerie A. Clausen, Amy Simon, Verena Karsten, Renta Hutabarat and Akshay Vaishnaw and has published in prestigious journals such as The Lancet, Blood and The American Journal of Medicine.

In The Last Decade

Timothy Mant

42 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

2013 467 citations Renta Hutabarat, Timothy Mant et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Mant United Kingdom	20	394	393	256	214	171	42	1.6k
Sven Hoffmeyer Germany	14	724 1.8×	402 1.0×	190 0.7×	96 0.4×	80 0.5×	19	3.6k
Michael D. Karol United States	21	433 1.1×	368 0.9×	112 0.4×	288 1.3×	122 0.7×	52	1.7k
Thomas Jax Germany	18	824 2.1×	581 1.5×	126 0.5×	66 0.3×	429 2.5×	44	2.7k
Hakan Çamlıca Türkiye	22	510 1.3×	198 0.5×	45 0.2×	100 0.5×	87 0.5×	68	1.5k
Siamak Davani France	15	275 0.7×	276 0.7×	241 0.9×	41 0.2×	186 1.1×	44	960
John F. Boylan United States	31	1.3k 3.2×	911 2.3×	111 0.4×	135 0.6×	435 2.5×	60	3.6k
Daniel L. Hertz United States	24	424 1.1×	122 0.3×	103 0.4×	344 1.6×	125 0.7×	132	2.7k
Demetrios Vlahakos Greece	26	392 1.0×	155 0.4×	245 1.0×	318 1.5×	385 2.3×	71	1.8k
Jingbo Zhang China	32	922 2.3×	280 0.7×	97 0.4×	116 0.5×	72 0.4×	91	2.8k
Xiaoyu Zhu China	25	459 1.2×	170 0.4×	346 1.4×	255 1.2×	21 0.1×	131	2.2k

Countries citing papers authored by Timothy Mant

Since Specialization

Citations

This map shows the geographic impact of Timothy Mant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Mant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Mant more than expected).

Fields of papers citing papers by Timothy Mant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Mant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Mant. The network helps show where Timothy Mant may publish in the future.

Co-authorship network of co-authors of Timothy Mant

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Mant. A scholar is included among the top collaborators of Timothy Mant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Mant. Timothy Mant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Howard, Jo, Claire Hemmaway, Paul Telfer, et al.. (2019). A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease. Blood. 133(17). 1865–1875. 84 indexed citations

Mehta, Mitul A., Anne Schmechtig, Juliet McColm, et al.. (2018). Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology. 235(7). 1875–1886. 31 indexed citations

Kirkham, Bruce, Christopher Hall, Toby Garrood, et al.. (2016). Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis. Lara D. Veeken. 55(11). 1993–2000. 34 indexed citations

Howard, Jo, Claire Hemmaway, Moji Awogbade, et al.. (2016). Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor. Blood. 128(22). 2488–2488. 11 indexed citations

Howard, Jo, Claire Hemmaway, Moji Awogbade, et al.. (2015). GBT440, a Potent Anti-Sickling Hemoglobin Modifier Reduces Hemolysis, Improves Anemia and Nearly Eliminates Sickle Cells in Peripheral Blood of Patients with Sickle Cell Disease. Blood. 126(23). 542–542. 20 indexed citations

Sah, Dinah W.Y., Qingmin Chen, Anthony Rossomando, et al.. (2011). ALN-TTR, an RNAI therapeutic for the treatment of transthyretin amyloidosis. Nucleic Acid Therapeutics. 21(5). 1 indexed citations

Mant, Timothy, et al.. (2011). Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers. International Immunopharmacology. 11(11). 1837–1843. 5 indexed citations

Vanover, Kimberly E., et al.. (2007). Pharmacokinetics, Tolerability, and Safety of ACP‐103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(6). 704–714. 30 indexed citations

Vanover, Kimberly E., et al.. (2007). The Effects of Food on the Pharmacokinetics of a Formulated ACP‐103 Tablet in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(7). 915–919. 14 indexed citations

10.

Mant, Timothy, et al.. (2006). Pharmacokinetics and safety assessments of high‐dose and 4‐week treatment with S‐3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers. British Journal of Clinical Pharmacology. 63(5). 512–526. 5 indexed citations

11.

Sewell, K. Lea, Richard S. Geary, Brenda F. Baker, et al.. (2002). Phase I Trial of ISIS 104838, a 2′-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-α. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1334–1343. 99 indexed citations

12.

Mant, Timothy, et al.. (2002). Absence of Interaction of Fondaparinux Sodium with Digoxin in Healthy Volunteers. Clinical Pharmacokinetics. 41(Supplement 2). 39–45. 21 indexed citations

13.

Dutta, Sandeep, et al.. (2001). Effect of dexmedetomidine on propofol requirements in healthy subjects. Journal of Pharmaceutical Sciences. 90(2). 172–181. 78 indexed citations

14.

Bokor, Daniela, John B. Chambers, P. J. Rees, et al.. (2001). Clinical Safety of SonoVue™, a New Contrast Agent for Ultrasound Imaging, in Healthy Volunteers and in Patients with Chronic Obstructive Pulmonary Disease. Investigative Radiology. 36(2). 104–109. 95 indexed citations

15.

Davies, P. M., H. Anne Simmonds, Brett C. Singer, et al.. (1998). Plasma Uridine as well as Uric Acid is Elevated Following Fructose Loading. Advances in experimental medicine and biology. 431. 31–35. 4 indexed citations

16.

Mant, Timothy, et al.. (1996). The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects. Journal of Antimicrobial Chemotherapy. 38(6). 1023–1029. 24 indexed citations

17.

Ingwersen, Steen H., et al.. (1993). Nonlinear Multiple-Dose Pharmacokinetics of the Dopamine Reuptake Inhibitor Vanoxerine. Journal of Pharmaceutical Sciences. 82(11). 1164–1166. 10 indexed citations

18.

Jones, Ronald M., J. N. Cashman, & Timothy Mant. (1990). CLINICAL IMPRESSIONS AND CARDIORESPIRATORY EFFECTS OF A NEW FLUORINATED INHALATION ANAESTHETIC, DESFLURANE (1–653), IN VOLUNTEERS. British Journal of Anaesthesia. 64(1). 11–15. 41 indexed citations

19.

Rademaker, Marius, E D Cooke, N. E. Almond, et al.. (1989). Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.. BMJ. 298(6673). 561–564. 155 indexed citations

20.

Mant, Timothy, et al.. (1984). ABC of poisoning. Respiratory drugs.. BMJ. 289(6452). 1133–1135. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact